Clinical Trial Update: APL93: Timing of CxT and Role of Maintenance [Phase 3]

View source ↗

Summary

A Phase 3 trial (APL93) evaluated the timing of consolidation therapy and the role of maintenance in acute promyelocytic leukemia; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Snippet

Sponsor: Groupe d'etude et de travail sur les leucemies aigues promyelocytaires | Conditions: Leukemia, Promyelocytic, Acute | Phase 3 | Status: COMPLETED